Welcome to LookChem.com Sign In|Join Free
  • or
(2S)-2-(3-((1S)-1-carboxy-5-(11-(4-(4-((2-(2-(2-carboxyethoxy)ethoxy)ethyl)amino)-6-((4-((1,4,7,10-tetrakis(carboxymethyl)-1,4,7,10-tetraazacyclododecan-2-yl)methyl)phenyl)amino)-1,3,5-triazin-2-yl)piperazin-1-yl)undecanamido)pentyl)ureido)pentanedioic acid is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1620171-98-3

Post Buying Request

1620171-98-3 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1620171-98-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1620171-98-3 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,6,2,0,1,7 and 1 respectively; the second part has 2 digits, 9 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 1620171-98:
(9*1)+(8*6)+(7*2)+(6*0)+(5*1)+(4*7)+(3*1)+(2*9)+(1*8)=133
133 % 10 = 3
So 1620171-98-3 is a valid CAS Registry Number.

1620171-98-3Upstream product

1620171-98-3Downstream Products

1620171-98-3Relevant academic research and scientific papers

TRIAZINE BASED RADIOPHARMACEUTICALS AND RADIOIMAGING AGENTS

-

Paragraph 0215; 0216, (2014/07/23)

Compounds according to Formula (I) and Formula (II) are potent inhibitors of PSMA. (I) or (II) Pharmaceutical compositions may include a complex of a radionuclide and a Formula (I) compound or a Formula (II) compound. Methods include using the radionuclide complex of a Formula (I) compound or a Formula (II) compound for treating or diagnosis of a disease or a condition associated with PSMA activity.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1620171-98-3